Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

24 Apr, 2017, 02:00 ET SIR-Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows

459-patient SARAH Study shows that local treatments of advanced or inoperable Hepatocellular Cancer (HCC) with SIR-Spheres Y-90 resin...


24 Apr, 2017, 01:00 ET Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicine Agency's (EMA) Committee for Medicinal...


23 Apr, 2017, 22:54 ET Une nouvelle analyse d'une étude britannique démontre que la rifaximine-α réduit considérablement le nombre de visites aux urgences chez les patients atteints d'encéphalopathie hépatique

Norgine B.V. a présenté aujourd'hui une nouvelle analyse de l'étude britannique en situation réelle IMPRESS, qui démontre que le traitement de...


23 Apr, 2017, 22:52 ET Rifaximin-α: neue Analyse der Studie in Großbritannien zeigt eine signifikante Reduktion der Anzahl an Behandlungen von Patienten mit hepatitischer Enzephalopathie in der Notaufnahme

Norgine B.V. legte heute eine neue Analyse der in Großbritannien durchgeführten praxisbezogenen Studie IMPRESS vor, die belegt, dass eine...


22 Apr, 2017, 10:00 ET NGM Bio Announces NGM282 Dramatically Reduced Liver Fat and Other Biomarkers Associated With Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial

NGM Bio announced that its lead product candidate, NGM282, met the primary endpoint and key secondary endpoints in a Phase 2 trial of patients with...


22 Apr, 2017, 08:00 ET Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S-649266), a Siderophore Cephalosporin

Shionogi & Co., Ltd. today announced it will present for the first time clinical trial efficacy results, as well as supportive in vitro data,...


21 Apr, 2017, 16:30 ET Research and Markets - Global $2.47 Billion Acquired Hemophilia Treatment Market, 2023: Key Players are Baxalta, Novo Nordisk, Biogen, Pfizer & F. Hoffman La Roche

Research and Markets has announced the addition of the "Global Acquired Hemophilia Treatment Market Size, Market Share, Application Analysis,...


21 Apr, 2017, 16:15 ET Global Algae Products Market, 2023: Growing Demand From the Nutraceuticals and Pharmaceutical Industries - Research and Markets

Research and Markets has announced the addition of the "Global Algae Products Market Size, Market Share, Application Analysis, Regional Outlook,...


21 Apr, 2017, 16:13 ET PCMA: New Analysis Finds C-THRU Act Would Increase Federal Spending by $20 Billion

A new Moran Company study examining the budgetary impact of S. 637, "Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act," introduced...


21 Apr, 2017, 16:01 ET Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the completion of its previously announced underwritten public offering of 69,000,000...


21 Apr, 2017, 16:00 ET Everolimus Sales, Price Analysis, & Sales Forecasts 2016-2021 - Research and Markets

Research and Markets has announced the addition of the "Everolimus Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 16:00 ET Amgen Announces Webcast Of 2017 First Quarter Financial Results

Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Wednesday, April 26, 2017, after the close of the...


21 Apr, 2017, 15:45 ET Doxorubicin Sales, Price Analysis, & Sales Forecasts 2016-2021 - Research and Markets

Research and Markets has announced the addition of the "Doxorubicin Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 15:30 ET Guaifenesin Sales, Price Analysis, & Sales Forecast 2017-2021 - Research and Markets

Research and Markets has announced the addition of the "Guaifenesin Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 15:00 ET CSSi LifeSciences™ Executives Featured at Colorado BioScience Association BioBoot Camp 2017

Today, Friday, April 21, 2017, members of CSSi LifeSciences™'s executive team served as featured speakers for BioBoot Camp 2017, a signature...


21 Apr, 2017, 13:45 ET Exemestane Sales, Price Analysis, & Sales Forecast 2016-2021 - Research and Markets

Research and Markets has announced the addition of the "Exemestane Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 13:30 ET Granisetron Sales, Price Analysis, & Sales Forecast - 2017 - Research and Markets

Research and Markets has announced the addition of the "Granisetron Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 13:29 ET BioMarin Receives Positive CHMP Opinion in Europe for Brineura™ (cerliponase alfa) for First Treatment of CLN2 Disease, a Form of Batten Disease and Ultra-Rare and Fatal Brain Disorder in Children

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee...


21 Apr, 2017, 13:15 ET Griseofulvin Sales, Price Analysis, & Sales Forecast Report 2017 - Research and Markets

Research and Markets has announced the addition of the "Griseofulvin Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 13:00 ET Naproxen Market Global Trends With Focus on North America, EU, China and Japan Regions - ReportsnReports.com

Naproxen market 2017 research report is an in-depth study and analysis of the market by our industry experts with unparalleled domain knowledge....


21 Apr, 2017, 13:00 ET Mast Therapeutics Announces Adjournment Of Special Stockholders Meeting

Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that the Special Meeting of Stockholders held earlier today was convened and...


21 Apr, 2017, 12:00 ET CVS Health Corporation To Hold First Quarter 2017 Conference Call

CVS Health Corporation (NYSE: CVS) will be holding a conference call on Tuesday, May 2, 2017, at 8:30 a.m. (ET) with analysts and investors to...


21 Apr, 2017, 10:00 ET FDA Allows novel inhaled treatment BIO-11006 to commence human trials in adults with lung cancer.

North Carolina based Biomarck Pharmaceuticals, Inc. has received FDA allowance l to begin human trials for their patented compound BIO-11006, for...


21 Apr, 2017, 09:45 ET Global Proteomics Technologies, Markets and Companies Report 2017-2026: 300+ Companies Identified in Proteomics - 224 Profiles with 456 Collaborations - Research and Markets

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Proteomics - Technologies, Markets and Companies" to their...


21 Apr, 2017, 09:01 ET Global Translational Regenerative Medicine Market Prospects 2017-2027

Stem Cell Therapies, Tissue Engineered Products, Gene Therapies The translational regenerative medicine market has been undergoing considerable...